Merck & Co Inc (MRK)

80.91 -0.11  -0.14% NYSE Aug 10, 16:58 USD

Merck Cash from Investing (TTM):

-3.082B for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 -3.082B
March 31, 2020 -4.625B
Dec. 31, 2019 -2.629B
Sept. 30, 2019 312.00M
June 30, 2019 1.781B
March 31, 2019 4.879B
Dec. 31, 2018 4.314B
Sept. 30, 2018 2.078B
June 30, 2018 1.089B
March 31, 2018 -711.00M
Dec. 31, 2017 2.679B
Sept. 30, 2017 174.00M
June 30, 2017 -1.387B
March 31, 2017 -1.758B
Dec. 31, 2016 -3.21B
Sept. 30, 2016 -1.264B
June 30, 2016 -435.00M
March 31, 2016 3.588B
Dec. 31, 2015 -4.758B
Sept. 30, 2015 3.063B
June 30, 2015 -598.00M
March 31, 2015 -3.172B
Dec. 31, 2014 -374.00M
Sept. 30, 2014 -6.401B
June 30, 2014 -4.716B
   
March 31, 2014 -5.802B
Dec. 31, 2013 -3.148B
Sept. 30, 2013 -8.723B
June 30, 2013 -8.525B
March 31, 2013 -7.688B
Dec. 31, 2012 -6.805B
Sept. 30, 2012 -4.091B
June 30, 2012 -2.515B
March 31, 2012 -3.265B
Dec. 31, 2011 -2.89B
Sept. 30, 2011 -2.213B
June 30, 2011 -1.756B
March 31, 2011 -244.00M
Dec. 31, 2010 -3.497B
Sept. 30, 2010 -15.35B
June 30, 2010 -3.537B
March 31, 2010 -1.382B
Dec. 31, 2009 3.156B
Sept. 30, 2009 15.57B
June 30, 2009 281.10M
March 31, 2009 -2.347B
Dec. 31, 2008 -1.834B
Sept. 30, 2008 -2.232B
June 30, 2008 975.80M
March 31, 2008 374.20M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

Benchmarks
Gilead Sciences Inc -6.777B
Johnson & Johnson -11.09B
Eli Lilly and Co -1.736B

Cash from Investing (TTM) Range, Past 5 Years

Minimum -4.758B Dec 2015
Maximum 4.879B Mar 2019
Average 4.90M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.